Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision entry (v3.7.0) is added to the record history, and the prior v3.6.6 entry is removed. This reflects a minor system/version update to the page rather than changes to trial data.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer shows a new revision label as part of a minor maintenance update, replacing the previous version. This change does not affect the study content or user interactions.SummaryDifference0.1%

- Check40 days agoChange DetectedA new study-record version (13) was added, with the record returned for quality control on 2026-08-14 and QC not concluded; multiple sections of the record were updated, including Study Status, Study Description, Arms/Interventions, Eligibility, Outcomes, and Contacts/Locations.SummaryDifference2%

- Check47 days agoChange DetectedThe revision history now shows a new entry labeled v3.6.5, replacing the previous v3.6.4. This reflects an update to the page's version-tracking in the history view.SummaryDifference0.1%

- Check62 days agoChange DetectedA new version (Revision: v3.6.4) adds the 'Results Submitted' status, replacing the prior 'No Results Posted' from v3.6.3, signaling that the trial results are being submitted for posting.SummaryDifference0.2%

- Check83 days agoChange DetectedA new revision entry v3.6.3 is added and the previous v3.6.2 revision is removed in the study record history, indicating a metadata update to the page’s history rather than substantive changes to the study data.SummaryDifference0.1%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.